Related Experiment Video
Updated: Jun 21, 2026
Mouse Models for Graft Arteriosclerosis
Published on: May 14, 2013
Cardiac allograft vasculopathy: pathology, prevention and treatment
1University of Ottawa Heart Institute, Division of Cardiology, Ottawa, Ontario, Canada.
Insights
Graft coronary artery disease significantly impacts long-term survival after heart transplantation. Early diagnosis and prevention strategies are crucial for improving outcomes in transplant recipients.
Area of Science:
- Cardiology
- Transplantation Immunology
- Vascular Biology
Background:
- Cardiac transplantation is a vital treatment for end-stage heart failure.
- Graft coronary artery disease (GCAD) is a primary factor limiting long-term survival post-transplant.
- GCAD arises from diverse immunologic and non-immunologic factors, including HLA mismatch, infections, and recipient comorbidities.
Purpose of the Study:
- To review the pathophysiology of graft coronary artery disease.
- To discuss current diagnostic and therapeutic options for GCAD.
- To explore future directions in managing GCAD.
Main Methods:
- Literature review of immunologic and non-immunologic etiologies of GCAD.
- Analysis of diagnostic challenges and limitations of conventional angiography and intravascular ultrasonography.
- Evaluation of current treatment strategies and preventive measures.
Main Results:
- GCAD diagnosis is challenging due to allograft de-innervation and diffuse involvement of small-to-medium arteries.
- Conventional angiography may miss GCAD, while intravascular ultrasonography has limitations in visualizing the entire arterial system.
- Treatment is often difficult, highlighting the importance of prevention through endothelial protection, reduced ischemic time, and risk factor management.
Conclusions:
- Understanding GCAD pathophysiology is key to developing effective interventions.
- Improved diagnostic tools and targeted therapies are needed.
- Prevention, encompassing pre-, peri-, and post-transplant strategies, is paramount for long-term graft survival.
Purpose Of Review:
Cardiac transplantation is a recognized therapy for end-stage heart failure. Graft coronary artery disease is a chief determinant of long-term survival following cardiac transplantation. There are multiple purported etiologies for graft coronary artery disease including both immunologic and nonimmunologic factors. Immunologic factors include human leukocyte antigen mismatching, cytokine production, and activation of the cellular immune system. Nonimmunologic factors include diabetes, hypertension, hyperlipidemia, and cytomegalovirus infection, just to name a few. There are also donor and recipient factors including age, prior coronary artery disease in the donor heart, and mode of donor brain death.
Recent Findings:
The diagnosis of graft coronary artery disease is especially difficult, partially due to the de-innervated allograft, as well as to its inherent predilection to affect the medium-sized and smaller arteries in a concentric and diffuse nature. Conventional angiography can overlook this condition because of the lack of eccentric plaques in larger epicardial arteries. Intravascular ultrasonography, by contrast, is more sensitive in detecting graft coronary artery disease but is unable to visualize the entire arterial system. Treatment is challenging and often unrewarding, leading to re-transplantation. Prevention is therefore ideal and involves protection against endothelial injury before and during transplantation as well as after transplantation, with decreased ischemic time, aggressive attention to early rejection, risk factor modification, and close follow-up.
Summary:
This review will look at the pathophysiology of graft coronary artery disease, current diagnostic and therapeutic choices, as well as existing and future directions.
